Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab vs azathioprine for prevention of postoperative recurrence in Crohn's disease
2011-000885-36Phase 3Completed
- Sponsor
- GETECCU
- Start
- Nov 2011
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Crohn's disease comparing Adalimumab arm with Azathioprine arm (2 arms). Started Nov 2011; status: completed.
02
Drugs
adalimumabazathioprine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2011-000885-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000885-36.